期刊文献+

伊贝沙坦治疗高血压及对左心室肥厚和舒张功能影响的临床研究 被引量:1

Effect of Irbesartan on Hypertension and Left Ventricular Hypertrophy and Diastolic Function in Patients with Essential Hypertension
下载PDF
导出
摘要 目的 观察伊贝沙坦对原发性高血压患者的降压疗效及左心室肥厚和舒张功能的影响。方法 对54例l~2级原发性高血压患者给予口服伊贝沙坦150~300mg,治疗24用,观察治疗前、后血压变化,并用超声心动图观察治疗前、后左室结构和舒张功能变化。结果 原发性高血压患者伊贝沙坦治疗后,收缩压和舒张压均较治疗前差异有显著性意义(P〈0.05),左室质量指数(LVMI),心室舒张功能较治疗前差异有显著性意义(P〈0.01),不良反应轻微。结论 伊贝沙坦有较好的降压疗效,并可逆转左心室肥厚及改善左心室舒张功能。 Objective To observe antihypertensive effect of irbesartan and its impact on left ventricular hypertrophy and diastolic function in patients with essential hypertension. Methods Fifty - four patients with 1~2 stage essential hypertension were given irbesartan 100 -300mg/d for twenty -four weeks. The change of blood pressure before and after treatment was observed, and the changes of left ventrieular structure and diastolic function before and after treatment were examined with echocardiography. Results After treatment with irbesartan, both systolic and diastolic pressure of the patients decreased ( P 〈 0. 05) , the left ventricular mass index significantly decreased ( P 〈0. 01 ) , and the left ventrieular diastolic function was obviously improved ( P 〈0. 01 ). Conclusion Irbesartan is effective for treatment of hypertension. Irbesartan can reverse left ventricular hypertrophy, and improve left ventricular diastolic function.
出处 《中国全科医学》 CAS CSCD 2006年第3期212-213,共2页 Chinese General Practice
关键词 伊贝沙坦 高血压 左室肥厚 左室舒张功能 Irbesartan Hypertension Left ventricular hypertrophy Left ventricular diastolic function
  • 相关文献

参考文献3

二级参考文献19

  • 1胡大一,赵秀丽.血管紧张素Ⅱ受体拮抗剂治疗高血压的研究进展[J].现代康复,1999,3(10):1204-1206. 被引量:6
  • 2刘国仗,刘力生.高血压左室肥厚与逆转[J].中国循环杂志,1993,8(12):707-707. 被引量:46
  • 3Prisont LM, Weir MR, Papademetrion V, et al. Low-dose druy combination therapy :an alternative first line approch to hypertension treatment[J] .Am Heart J, 1995,130(6) :359-366.
  • 4Leeuw PW, Notter T, Zilles P. Comparison of different fixed antinpertentive combination drugs: a doublind, placebo-Comtrolled parallcl group study[ J]. J Hypertens, 1997,15 ( 1 ) : 87-91.
  • 5Andren B, Lind L, Lithell H. The influence of different antihypertensive drugs on left ventrieular hypertrophy in a population sample of elderly men [ J ]. J Hum Hypertens, 1999,13 ( 8 ) : 499-504.
  • 6Morgan HE, Baker KH. Cardiac hypertrophy: mechanica, neural, and endocrine dependence [ J ]. Circulation, 1991,83 ( 1 ) : 13-25.
  • 7Kent R,Hooberk G,Coopor VG.Load responses of protein synthesis in adult mammalian myoeardiam : role of cardiac defermation linked to sodium influs[ J] .Cir Res, 1989,64(2) :74-85.
  • 8Michel TB,Salzmann JL, Cerol MDL, et al. Myocardial effects of converting enzyme inhibition in hypertensive and normotensive rats[ J]. Am J Med, 1988,84[ Supple 3A ] : 12-14.
  • 9Matsui H, Makino N, Yano K, et al. Modulation of adrenergic receptors during regression of cardiac hypertrophy [J]. J Hypertens, 1994, 12( 11 ) : 1353-1357.
  • 10Weker KJ, Bfila CG. PathoUgical hypertrophy and cardiac nterstitium[J]. Circulation, 1991,83(14) : 1862.

共引文献47

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部